n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate has been researched along with Urinary Bladder, Neurogenic in 1 studies
*Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komatsu, K; Kontani, H; Nakamura, Y; Namiki, M; Tanaka, T; Yokoyama, O | 1 |
1 other study(ies) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Effects of adenosine triphosphate dependent potassium channel opener on bladder overactivity in rats with cerebral infarction.
Topics: Animals; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Pons; Potassium Channels; Pyridines; Rats; Rats, Sprague-Dawley; Urinary Bladder, Neurogenic; Urodynamics | 2002 |